NVIDIA's official blog post highlights that startups in its Inception program are leveraging AI to address multiple challenges in breast cancer diagnosis and treatment in the U.S. Among them, iSono Health has developed an FDA-cleared wearable 3D ultrasound system that uses AI to automate image acquisition, improving screening efficiency and accuracy. Whiterabbit.ai's FDA-cleared software, WRDensity, automatically assesses breast density and is developing AI technology to assist radiologists in cancer detection. Ataraxis AI builds clinical intelligence by analyzing pathology slides to predict patient responses to different therapies, aiming for personalized treatment.